TY - JOUR
T1 - Predicting the Need for Step-Up Therapy After EUS-Guided Drainage of Pancreatic Fluid Collections With Lumen-Apposing Metal Stents
AU - Chandrasekhara, Vinay
AU - Elhanafi, Sherif
AU - Storm, Andrew C.
AU - Takahashi, Naoki
AU - Lee, Nam Ju
AU - Levy, Michael J.
AU - Kaura, Karan
AU - Wang, Lillian
AU - Majumder, Shounak
AU - Vege, Santhi S.
AU - Law, Ryan J.
AU - Abu Dayyeh, Barham K.
N1 - Funding Information:
Vinay Chandrasekhara (Conceptualization: Lead; Formal analysis: Supporting; Investigation: Lead; Methodology: Lead; Writing – original draft: Lead), Sherif Elhanafi (Data curation: Equal; Formal analysis: Lead; Methodology: Equal; Validation: Equal; Writing – review & editing: Supporting), Andrew C. Storm (Investigation: Supporting; Writing – review & editing: Supporting), Naoki Takahashi (Data curation: Supporting; Methodology: Supporting; Writing – review & editing: Supporting), Nam Ju Lee (Data curation: Supporting; Writing – review & editing: Supporting), Michael J. Levy (Data curation: Supporting; Writing – review & editing: Supporting), Karan Kaura (Data curation: Supporting; Writing – review & editing: Supporting), Lillian Wang (Data curation: Supporting; Writing – review & editing: Supporting), Shounak Majumder (Writing – review & editing: Supporting), Santhi S. Vege (Writing – review & editing: Supporting), Ryan J. Law (Writing – review & editing: Supporting), Barham K. Abu Dayyeh (Conceptualization: Supporting; Formal analysis: Supporting; Investigation: Supporting; Writing – review & editing: Supporting) Conflicts of interest These authors disclose the following: Vinay Chandrasekhara reports Medical Advisory Board for Interpace diagnostics; shareholder for Nevakar Corporation; and a consultant for Covidien LLP. Andrew C. Storm reports consultant for GI Dynamics (DSMB) and ERBE (DSMB); consultant and research support/grant for Endo-TAGSS and Apollo Endosurgery; and research support/grant for Boston Scientific. Ryan J. Law reports consultant for Olympus and Covidien LLP. Barham K. Abu Dayyeh reports consultant and research support/grant for Boston Scientific and USGI Medical; consultant for Metamodix, BFKW, and DyaMx; research support for Apollo Endosurgery, Spatz Medical, GI Dynamics, Caim Diagnostics, Aspire Bariatrics, and Medtronic; and speaker for Johnson & Johnson, Endogastric Solutions, and Olympus. The other authors disclose no conflicts.
Publisher Copyright:
© 2021 AGA Institute
PY - 2021/10
Y1 - 2021/10
N2 - Background & Aims: A significant proportion of individuals with pancreatic fluid collections (PFCs) require step-up therapy after endoscopic drainage with lumen-apposing metal stents. The aim of this study is to identify factors associated with PFCs that require step-up therapy. Methods: A retrospective cohort study of patients undergoing endoscopic ultrasound–guided drainage of PFCs with lumen-apposing metal stents from April 2014 to October 2019 at a single center was performed. Step-up therapy included direct endoscopic necrosectomy, additional drainage site (endoscopic or percutaneous), or surgical intervention after the initial drainage procedure. Multivariable logistic regression was performed using a backward stepwise approach with a P ≤ .2 threshold for variable retention to identify factors predictive for the need for step-up therapy. Results: One hundred thirty-six patients were included in the final study cohort, of whom 69 (50.7%) required step-up therapy. Independent predictors of step-up therapy included: collection size measuring ≥10 cm (odds ratio [OR], 8.91; 95% confidence interval [CI], 3.36–23.61), paracolic extension of the PFC (OR, 4.04; 95% CI, 1.60–10.23), and ≥30% solid necrosis (OR, 4.24; 95% CI, 1.48–12.16). In a sensitivity analysis of 81 patients with walled-off necrosis, 51 (63.0%) required step-up therapy. Similarly, factors predictive of the need for step-up therapy for walled-off necrosis included: collection size measuring ≥10 cm (OR, 6.94; 95% CI, 1.76–27.45), paracolic extension of the PFC (OR, 3.79; 95% CI, 1.18–12.14), and ≥30% solid necrosis (OR, 7.10; 95% CI, 1.16–43.48). Conclusions: Half of all patients with PFCs drained with lumen-apposing metal stents required step-up therapy, most commonly direct endoscopic necrosectomy. Individuals with PFCs ≥10 cm in size, paracolic extension, or ≥30% solid necrosis are more likely to require step-up therapy and should be considered for early endoscopic reintervention.
AB - Background & Aims: A significant proportion of individuals with pancreatic fluid collections (PFCs) require step-up therapy after endoscopic drainage with lumen-apposing metal stents. The aim of this study is to identify factors associated with PFCs that require step-up therapy. Methods: A retrospective cohort study of patients undergoing endoscopic ultrasound–guided drainage of PFCs with lumen-apposing metal stents from April 2014 to October 2019 at a single center was performed. Step-up therapy included direct endoscopic necrosectomy, additional drainage site (endoscopic or percutaneous), or surgical intervention after the initial drainage procedure. Multivariable logistic regression was performed using a backward stepwise approach with a P ≤ .2 threshold for variable retention to identify factors predictive for the need for step-up therapy. Results: One hundred thirty-six patients were included in the final study cohort, of whom 69 (50.7%) required step-up therapy. Independent predictors of step-up therapy included: collection size measuring ≥10 cm (odds ratio [OR], 8.91; 95% confidence interval [CI], 3.36–23.61), paracolic extension of the PFC (OR, 4.04; 95% CI, 1.60–10.23), and ≥30% solid necrosis (OR, 4.24; 95% CI, 1.48–12.16). In a sensitivity analysis of 81 patients with walled-off necrosis, 51 (63.0%) required step-up therapy. Similarly, factors predictive of the need for step-up therapy for walled-off necrosis included: collection size measuring ≥10 cm (OR, 6.94; 95% CI, 1.76–27.45), paracolic extension of the PFC (OR, 3.79; 95% CI, 1.18–12.14), and ≥30% solid necrosis (OR, 7.10; 95% CI, 1.16–43.48). Conclusions: Half of all patients with PFCs drained with lumen-apposing metal stents required step-up therapy, most commonly direct endoscopic necrosectomy. Individuals with PFCs ≥10 cm in size, paracolic extension, or ≥30% solid necrosis are more likely to require step-up therapy and should be considered for early endoscopic reintervention.
KW - Acute Pancreatitis
KW - EUS
KW - Lumen-Apposing Metal Stents
KW - Pseudocyst
KW - Walled-Off Necrosis
UR - http://www.scopus.com/inward/record.url?scp=85108533476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108533476&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2021.05.005
DO - 10.1016/j.cgh.2021.05.005
M3 - Article
C2 - 33965573
AN - SCOPUS:85108533476
SN - 1542-3565
VL - 19
SP - 2192
EP - 2198
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 10
ER -